Insertion of a foreign sequence on capsid surface loops of human papillomavirus type 16 virus-like particles reduces their capacity to induce neutralizing antibodies and delineates a conformational neutralizing epitope

被引:52
|
作者
Sadeyen, JR
Tourne, S
Shkreli, M
Sizaret, PY
Coursaget, P
机构
[1] Fac Pharmaceut Sci, INSERM EMIU 00 10, Mol Virol Lab, F-37200 Tours, France
[2] Fac Pharmaceut Sci, USC INRA, IFR 82 Transposons & Virus, F-37200 Tours, France
[3] Fac Med, Lab Microscopie Electron, IFR 82 Transposons & Virus, Tours, France
关键词
HPV; hepatitis B core; immunogenicity; antigenicity;
D O I
10.1016/S0042-6822(02)00134-4
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The aims of this study were to generate chimeric human papillomavirus (HPV)-16 L1 virus-like particles (VLPs) in order to identify immunogenic domains and conformational neutralizing epitopes, and to characterize the regions where a foreign epitope could be introduced. We hypothesized that these regions could be on L1 protein loops since they are exposed on the surface of VLPs. The aims of this study were achieved by mutating HPV-16 L1 proteins. Six amino acids encoding for the epitope 78-83 (DPASRE) of the hepatitis B core (HBc) antigen were introduced within the different loops of the L1 protein at positions 56/57, 140/141, 179/180, 266/267, 283/284 or 352/353. All these chimeric L1 proteins were capable of self-assembly into VLPs. The antigenicity and immunogenicity of some of these VLPs were reduced compared to the levels observed with wild-type VLPs. All were nevertheless able to induce neutralizing antibodies. VLPs with insertion at position 266/267 induced lower levels of neutralizing antibodies, suggesting the involvement of residues situated on FG loop in L1 neutralizing epitopes. All the chimeric L1 proteins except the one with insertion at position 56/57 were also able to induce anti-HBc antibodies, thus suggesting exposure of the HBc epitope on the VLP surface. Taken together, our findings indicate the possibility of designing HPV-derived vectors that are less immunogenic and suggest positions for insertion of defined immune epitopes or cell ligands into L1 protein to be exposed on the surface of VLPs. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:32 / 40
页数:9
相关论文
共 42 条
  • [21] Immunogenic display of diverse peptides, including a broadly cross-type neutralizing human papillomavirus L2 epitope, on virus-like particles of the RNA bacteriophage PP7
    Caldeira, Jerri do Carmo
    Medford, Alexander
    Kines, Rhonda C.
    Lino, Christopher A.
    Schiller, John T.
    Chackerian, Bryce
    Peabody, David S.
    VACCINE, 2010, 28 (27) : 4384 - 4393
  • [22] Human papillomavirus type 58 L1 virus-like particles purified by two-step chromatography elicit high levels of long-lasting neutralizing antibodies
    Xie, Xixiu
    Liu, Yanchun
    Zhang, Ting
    Xu, Yanying
    Bao, Qifeng
    Chen, Xue
    Liu, Hongyang
    Xu, Xuemei
    ARCHIVES OF VIROLOGY, 2013, 158 (01) : 193 - 199
  • [23] Human papillomavirus type 58 L1 virus-like particles purified by two-step chromatography elicit high levels of long-lasting neutralizing antibodies
    Xixiu Xie
    Yanchun Liu
    Ting Zhang
    Yanying Xu
    Qifeng Bao
    Xue Chen
    Hongyang Liu
    Xuemei Xu
    Archives of Virology, 2013, 158 : 193 - 199
  • [24] Prevalence of antibodies to human papillomavirus (HPV) type 16 virus-like particles in relation to cervical HPV infection among college women
    Viscidi, RP
    Kotloff, KL
    Clayman, B
    Russ, K
    Shapiro, S
    Shah, KV
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1997, 4 (02) : 122 - 126
  • [25] Human papillomavirus 16L1-58L2 chimeric virus-like particles elicit durable neutralizing antibody responses against a broad-spectrum of human papillomavirus types
    Chen, Xue
    Liu, Hongyang
    Wang, Zhirong
    Wang, Shuo
    Zhang, Ting
    Hu, Meili
    Qiao, Liang
    Xu, Xuemei
    ONCOTARGET, 2017, 8 (38) : 63333 - 63344
  • [26] Recombinant human immunodeficiency Pr55(gag) virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies
    Deml, L
    Schirmbeck, R
    Reimann, J
    Wolf, H
    Wagner, R
    VIROLOGY, 1997, 235 (01) : 26 - 39
  • [27] Human papillomavirus type II (HPV-11) neutralizing antibodies in the serum and genital mucosal secretions of African green monkeys immunized with HPV-11 virus-like particles expressed in yeast
    Lowe, RS
    Brown, DR
    Bryan, JT
    Cook, JC
    George, HA
    Hofmann, KJ
    Hurni, WM
    Joyce, JG
    Lehman, ED
    Markus, HZ
    Neeper, MP
    Schultz, LD
    Shaw, AR
    Jansen, KU
    JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (05): : 1141 - 1145
  • [28] Sequence conservation within the major capsid protein of human papillomavirus (HPV) type 18 and formation of HPV-18 virus-like particles in Saccharomyces cerevisiae
    Hofmann, KJ
    Neeper, MP
    Markus, HZ
    Brown, DR
    Muller, M
    Jansen, KU
    JOURNAL OF GENERAL VIROLOGY, 1996, 77 : 465 - 468
  • [29] Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16
    Varsani, A
    Williamson, AL
    de Villiers, D
    Becker, I
    Christensen, ND
    Rybicki, EP
    JOURNAL OF VIROLOGY, 2003, 77 (15) : 8386 - 8393
  • [30] Induction of mucosal and systemic neutralizing antibodies against human immunodeficiency virus type 1 (HIV-1) by oral immunization with bovine papillomavirus-HIV-1 gp41 chimeric virus-like particles
    Zhang, HT
    Huang, YJ
    Fayad, R
    Spear, GT
    Qiao, L
    JOURNAL OF VIROLOGY, 2004, 78 (15) : 8342 - 8348